A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma

ClinicalTrials.gov ID: NCT01378871

Public ClinicalTrials.gov record NCT01378871. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jun 25, 2026, 9:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma

Study identification

NCT ID: NCT01378871
Recruitment status: Terminated
Study type: Interventional
Phase: Phase 2
Lead sponsor: Amit Verma; Other
Enrollment: 1 participant

Conditions and interventions

Conditions

Interventions

IMTOX-25 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 31, 2010
Primary completion: Dec 31, 2012
Completion: Dec 31, 2012
Last update posted: Jun 8, 2023

2010 – 2013

United States locations

U.S. sites: 7
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Albert Einstein Cancer Center at Albert Einstein College of Medicine	The Bronx	New York	10461	—
Albert Einstein Cancer Center	The Bronx	New York	10461	—
Albert Einstein Comprehensive Cancer Center	The Bronx	New York	10461	—
Montefiore Medical Center	The Bronx	New York	10461	—
Albert Einstein Clinical Cancer Center	The Bronx	New York	10467	—
Montefiore Medical Center-	The Bronx	New York	10467	—
Montefiore Medical Center	The Bronx	New York	10467	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01378871, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 8, 2023 · Synced Jun 25, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01378871 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →